Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Boris Julg

Showing results (1-10 of 66) with videos related to

Pageof 7
Sort By:
Immunity|June 23, 2016
Broadly Neutralizing Antibodies: Magic Bullets against HIV?Boris Julg, Galit Alter
Translational Research : the Journal of Laboratory and Clinical Medicine|May 22, 2020
Therapeutic Vaccines for the Treatment of HIVZhilin Chen, Boris Julg
The Journal of Clinical Investigation|May 22, 2018
Lymph node fibrosis: a structural barrier to unleashing effective vaccine immunityBoris Julg, Galit Alter
Seminars in Immunology|April 16, 2021
Broadly neutralizing antibodies for HIV-1 prevention and therapyBoris Julg, Dan Barouch
Immunity|October 19, 2017
HIV-1 Latency by TransitionBoris Julg, Dan H Barouch
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 7, 2009
The paradox of incomplete CD4+ cell count restoration despite successful antiretroviral treatment and the need to start highly active antiretroviral therapy earlyBoris Julg, Bruce D Walker
Therapeutics and Clinical Risk Management|October 2, 2008
Atriplatrade mark - HIV therapy in one pillBoris Julg, Johannes R Bogner
Current Opinion in HIV and AIDS|May 15, 2019
Neutralizing antibodies for HIV-1 preventionBoris Julg, Dan H Barouch
The Journal of Infectious Diseases|February 15, 2021
Antibodies for Human Immunodeficiency Virus-1 Cure StrategiesEvan Rossignol, Galit Alter, Boris Julg
Elife|May 4, 2023
Viral persistence, reactivation, and mechanisms of long COVIDBenjamin Chen, Boris Julg, Sindhu Mohandas, et al.
Pageof 7

Showing results (1-10 of 66) with videos related to

Sort By:
Pageof 7
Immunity|June 23, 2016
Broadly Neutralizing Antibodies: Magic Bullets against HIV?Boris Julg, Galit Alter
Translational Research : the Journal of Laboratory and Clinical Medicine|May 22, 2020
Therapeutic Vaccines for the Treatment of HIVZhilin Chen, Boris Julg
The Journal of Clinical Investigation|May 22, 2018
Lymph node fibrosis: a structural barrier to unleashing effective vaccine immunityBoris Julg, Galit Alter
Seminars in Immunology|April 16, 2021
Broadly neutralizing antibodies for HIV-1 prevention and therapyBoris Julg, Dan Barouch
Immunity|October 19, 2017
HIV-1 Latency by TransitionBoris Julg, Dan H Barouch
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 7, 2009
The paradox of incomplete CD4+ cell count restoration despite successful antiretroviral treatment and the need to start highly active antiretroviral therapy earlyBoris Julg, Bruce D Walker
Therapeutics and Clinical Risk Management|October 2, 2008
Atriplatrade mark - HIV therapy in one pillBoris Julg, Johannes R Bogner
Current Opinion in HIV and AIDS|May 15, 2019
Neutralizing antibodies for HIV-1 preventionBoris Julg, Dan H Barouch
The Journal of Infectious Diseases|February 15, 2021
Antibodies for Human Immunodeficiency Virus-1 Cure StrategiesEvan Rossignol, Galit Alter, Boris Julg
Elife|May 4, 2023
Viral persistence, reactivation, and mechanisms of long COVIDBenjamin Chen, Boris Julg, Sindhu Mohandas, et al.
Pageof 7